MedicalSystem Biotechnology Co

MedicalSystem Biotechnology Co EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of MedicalSystem Biotechnology Co (300439.SZ) as of Oct 16, 2026 is 51.87. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -135.45 — a change of -138.29% (higher).

EV/FCF

51.87

YoY

-138.29%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of MedicalSystem Biotechnology Co is 2025 51.87 . EV/FCF (Enterprise Value to Free Cash Flow) of MedicalSystem Biotechnology Co was 2024 -135.45 . It decreases by -138.29% higher compared to the previous year.

The MedicalSystem Biotechnology Co EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-184.47 CNY
Jan 1, 2019
20.87 CNY
Jan 1, 2020
8.51 CNY
Jan 1, 2021
11.53 CNY
Jan 1, 2022
12.79 CNY
Jan 1, 2023
8.52 CNY
Jan 1, 2024
-135.45 CNY
Jan 1, 2025
51.87 CNY
The MedicalSystem Biotechnology Co EV/FCF history
YEAREV/FCFYoY
51.87-138.29%
-135.45-1,689.47%
8.52-33.39%
12.79+10.99%
11.53+35.44%
8.51-59.22%
20.87-111.32%
-184.47+2,012.36%
-8.73-37.43%
-13.96-134.88%
40.02-55.92%
90.79—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MedicalSystem Biotechnology Co Stock analysis

What does MedicalSystem Biotechnology Co do? MedicalSystem Biotechnology Co Ltd is a biotechnology company based in Ningbo, China, operating within the healthcare sector. The company focuses on the research, development, and manufacturing of bio-tech pharmaceutical products. It employs 2,473 full-time staff and completed its initial public offering (IPO) on April 22, 2015. MedicalSystem Biotechnology offers in-vitro diagnostic products, including reagents and instruments, and provides third-party medical diagnosis services. The company also produces and distributes reagent raw materials. Its primary market is domestic, with operations concentrated within China. The company's headquarters are located in Ningbo, Zhejiang Province. MedicalSystem Biotechnology's website is https://www.nbmksw.com/. The company's business activities include the development and production of diagnostic products, alongside the provision of related medical services. It operates as a public company listed on the Shenzhen Stock Exchange under the ticker symbol 300439.SZ and is identified by the ISIN CNE100001Z25. The company's operations are centered on the domestic Chinese market, with no indication of significant international presence. MedicalSystem Biotechnology is engaged in the production of pharmaceuticals and diagnostic tools, serving healthcare providers and institutions within China. MedicalSystem Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MedicalSystem Biotechnology Co stock

EV/FCF (Enterprise Value to Free Cash Flow) of MedicalSystem Biotechnology Co is 51.87 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of MedicalSystem Biotechnology Co changed from -135.45 to 51.87, representing a -138.29% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) MedicalSystem Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s MedicalSystem Biotechnology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — MedicalSystem Biotechnology Co

All Key Metrics — MedicalSystem Biotechnology Co